Facebook Instagram Linkedin Twitter Website
Home Blog Page 120

Nature’s Sunshine Products Inc. (NATR) Soars 6.05% on October 07

By
Editor
-
0

 

About 55,051 shares traded hands on 232 trades for the day, compared with an average daily volume of n/a shares out of a total float of 19.3 million. After opening the trading day at $8.15, shares of Nature’s Sunshine Products Inc. stayed within a range of $8.75 to $8.15.

With today’s gains, Nature’s Sunshine Products Inc. now has a market cap of $165.81 million. Shares of Nature’s Sunshine Products Inc. have been trading within a range of $10.73 and $6.12 over the last year, and it had a 50-day SMA of $n/a and a 200-day SMA of $n/a.

Natures Sunshine Products Inc is a natural health and wellness company, primarily engaged in the manufacturing and selling of nutritional and personal care products. The company markets its products in Australia, Austria, Belarus, Canada, Colombia, Costa Rica, the Czech Republic, Denmark, the Dominican Republic, Ecuador, El Salvador, Finland, Germany, Guatemala, Honduras, Hong Kong, and in various other countries. Business activity of the group is functioned through NSP Americas; NSP Russia, Central and Eastern Europe; Synergy Worldwide; and China. The company generates maximum revenue from the NSP Americas segment. It offers products related to general health, immunity, cardiovascular, digestive, personal care and weight management.

Nature’s Sunshine Products Inc. is based out of Lehi, UT and has some 905 employees. Its CEO is Terrence Moorehead.

For a complete fundamental analysis of Nature’s Sunshine Products Inc., check out Equities.com’s Stock Valuation Analysis report for NATR.

Still paying commissions on stock trades? Equities.com now offers $7.99/month unlimited trading and flat-fee options trading for $89.99/month! Get started today by https://www.equities.com/trading-start

Nature’s Sunshine Products Inc. is also a component of the Russell 2000. The Russell 2000 is one of the leading indices tracking small-cap companies in the United States. It’s maintained by Russell Investments, an industry leader in creating and maintaining indices, and consists of the smallest 2000 stocks from the broader Russell 3000 index.

Russell’s indices differ from traditional indices like the Dow Jones Industrial Average (DJIA) or S&P 500, whose members are selected by committee because they base membership entirely on an objective, rules-based methodology. The 3,000 largest companies by market cap make up the Russell 3000, with the 2,000 smaller companies making up the Russell 2000. It’s a simple approach that gives a broad, unbiased look at the small-cap market as a whole.

To get more information on Nature’s Sunshine Products Inc. and to follow the company’s latest updates, you can visit the company’s profile page here: NATR’s Profile. For more news on the financial markets and emerging growth companies, be sure to visit Equities.com’s Newsdesk. Also, don’t forget to sign-up for our daily email newsletter to ensure you don’t miss out on any of our best stories.

All data provided by QuoteMedia and was accurate as of 4:30 PM ET.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to http://www.equities.com/disclaimer

Vitality Reports Second Quarter Results

By
Editor
-
0

 

Vitality Products Inc. (the “Company” or “Vitality”) is pleased to announce it has achieved its highest sales quarter since the revitalization and launch of Vitality products in fiscal 2014.  Sales for the three months ended July 31, 2019 of the Company’s premium natural health products increased to $150,937 (2018 – $146,861) as the Company launched the new bottle size of 120 vegetable capsules of Vitality Power Iron + Organic Spirulina in June 2019.

The financial results of the Company for the three months ended July 31, 2019 show a net loss of $7,002 or $0.00 per share compared to a net loss of $265,776 or $0.01 per share for the same period last year.

“We are pleased with the traction Vitality has made in the natural health market, and the continued growth of Power Iron with the introduction of the new 120 vcap size, and additional shelf presence at leading retailers across Canada,” said Cheryl Grant, President and CEO.  “The Company continues to diversify sales from a few key groups over the last three years, to dozens of leading retailers which will provide a base of stability and future growth.”

The Company’s general and administrative expenses for the three months ended July 31, 2019 decreased to $115,383 (2018 – $370,774) as the Company recorded a share-based compensation expense of $Nil (2018 – $238,700).  The cost of sales increased to $39,365 (2018 – $38,451) and wages and salary increased to $50,301 (2018 – $41,348) due to the Company’s focus on expanding distribution and growing sales nationally and online.  The Company received $29,761 (2018 – $32,768) of government assistance that offset additional resources spent on the Vitality branding, products, marketing materials, website development, salaries and expanding distribution channels.

Vitality’s products are now available for sale in 575 retail stores (2018 – 550 retail stores) located in Canada and online at vitality.ca, amazon.ca and well.ca.  A full list of the retailers is available at www.vitality.ca.

The Company’s condensed interim financial statements and management’s discussion and analysis for the six months ended July 31, 2019 and 2018 are available on the SEDAR website at www.sedar.com.

Origin House Signs Distribution Agreement with California Cannabis-Infused Beverage Brand – Cannabiniers, and Provides Management Update

By
Editor
-
0

 

A North American cannabis products and brands company today announced that the Company’s distribution arm, Continuum, has entered into an agreement (the “Agreement“) to become the exclusive distributor of Cannabiniers™, producer of Two Roots™, Creative Waters™, and Baskin™ cannabis-infused products in California.

“Our California distribution platform continues to strengthen as we prepare for the closing of the acquisition of the Company by Cresco Labs Inc. (“Cresco Labs“), upon receipt of regulatory approvals” said Marc Lustig, Chairman and CEO of Origin House. “We believe infused beverages will be one of the key product categories of the future and are proud to partner with Cannabiniers – a well-known brewer and growing infused beverage brand. We continue to see signs that the California market is gaining momentum as focused efforts to put pressure on illegal players continue to shift dollars to the legal market.”

Michael Hayford, CEO of Lighthouse Strategies, parent company to Cannabiniers, added, “Cannabiniers and its portfolio of smoke-free, healthier cannabis products is committed to quality and focused on providing consumers with a discreet, authentic beverage experience. In our search for a distribution partner in the California market, Continuum emerged as the clear choice. Not only does the Company have a statewide distribution and support platform as well as relationships with a majority of legal dispensaries in the state, but the team on the ground in California truly understands how successful brands are built. We look forward to getting started and expect this to be a value-driving partnership for both of our organizations.”

The initial term of the Agreement is one year.

Cannabiniers is a developer of global cannabis brands that revolutionize the industry with first to market, patented, safe, fast-acting infusion technology. The company believes the future of cannabis consumption is dependent upon products that normalize personal and social usage without changing lifestyle patterns and behavioral norms. Two Roots is the world’s first non-alcoholic, cannabis-infused craft beer, available in three core styles, including: Lager, IPA, and Wheat, and seasonal brews, including its high-octane, cannabis flavored Straight Drank, which was developed in collaboration with Jetty Extracts. Creative Waters is its newest line of fast-acting, micro-dosed sparkling waters consisting of three CBD-infused flavors, as well as three additional flavors infused with a combined ratio of both CBD and THC, and Baskin is its line of cannabis-infused personal care products.

Management Team Update
Afzal Hasan, President and General Counsel, will be leaving the Company effective immediately. His departure was mutually planned to coincide with the Company’s current phase of development and in anticipation of the close of the acquisition of the Company by Cresco Labs.

A replacement President will not be sought. The Company has promoted its Associate General Counsels, Adrian Lambie for the US, and Pearl Chan for Canada, to the roles of General Counsel (US) and General Counsel (Canada), respectively.  Mr. Hasan will continue to advise the Company in a consulting role.

Regarding the departure of Mr. Hasan, Mr. Lustig commented, “Afzal played a pivotal role in the Company’s strategy and execution since being appointed President in early 2018. I sincerely thank him for his hard work and commitment to our company and we look forward to his continued contribution as a consultant to Origin House and to Cresco Labs following the anticipated closing of the acquisition.”

Forward Looking Statements
Statements in this news release that are forward-looking statements are subject to various risks and uncertainties concerning the specific factors disclosed here and elsewhere in Origin House’s periodic filings with Canadian securities regulators. When used in this news release, words such as “will, could, plan, estimate, expect, intend, may, potential, believe, should,” and similar expressions, are forward- looking statements.

Forward-looking statements may include, without limitation, statements relating to the timing and completion of the transactions and agreements contemplated in this press release (including without limitation, the acquisition of the Company by Cresco Labs), the future growth and environment of the California legal cannabis market, the execution of the Company’s strategy, new opportunities, the Company’s timing and process for expansion in Canada and globally, new opportunities, future growth and other statements.

Although the Company has attempted to identify important factors that could cause actual results, performance or achievements to differ materially from those contained in the forward-looking statements, there can be other factors that cause results, performance or achievements not to be as anticipated, estimated or intended, including, but not limited to: dependence on obtaining regulatory approvals; investing in target companies or projects that are engaged in activities currently considered illegal under US federal law; changes in laws; limited operating history; reliance on management; requirements for additional financing; competition; hindering market growth and state adoption due to inconsistent public opinion and perception of the medical-use and adult-use marijuana industry and; regulatory or political change.

There can be no assurance that such information will prove to be accurate or that management’s expectations or estimates of future developments, circumstances or results will materialize. As a result of these risks and uncertainties, the results or events predicted in these forward-looking statements may differ materially from actual results or events.

Accordingly, readers should not place undue reliance on forward-looking statements. The forward-looking statements in this news release are made as of the date of this release. The Company disclaims any intention or obligation to update or revise such information, except as required by applicable law, and the Company does not assume any liability for disclosure relating to any other company mentioned herein.

Gardein Launches More Plant Based Products- Answering the Demand for Great Tasting Food That Can Be Enjoyed All Day

By
Editor
-
0

 

Van Stolk says that the company has many more sustainability initiatives being planned for the near future that are aimed to “reimagine packaging” and empower customers to “be part of the solution”. With a delivery model based on a ardein, a brand of Conagra Brands, Inc. (NYSE: CAG) is answering the growing demand for plant-based food by expanding its line of meat-alternative dishes, including new items that feature breakfast saus’ages and single serve bowls. The products provide a variety of meal options for the entire day including breakfast, lunch and dinner.

Gardein delivers great taste, texture and is cholesterol-free with less saturated fat than traditional meat. All products are vegan and Non-GMO Project Verified. Gardein offers a variety of products that are nutritionally equivalent to meat and are gluten-free.

“We are very excited to continue to expand the Gardein line-up that was originally created by a Canadian chef to answer the desire for more plant-based foods!” said Ian Roberts, Vice President and General Manager at Conagra Brands Canada. “Gardein’s strength has always been its wide variety of delicious plant-based meat alternatives and it can now satisfy appetites at any time of the day.”

Gardein has a line-up of 24 delicious plant-based products including:

Breakfast Saus’ages- New

  • Three varieties – Maple, Original and Spicy with an SRP: $4.97

Single Serve Bowls- New

  • Three varieties – Chick’n Fajita, Teriyaki Chick’n and Orange Beefless with an SRP: $6.97

Over 18 additional Gardein SKU’s including:

  1. Gardein Seven Grain Crispy Tenders with an SRP of $5.49
  2. Gardein Mandarin Orange Crispy Chick’n with an SRP of $5.49
  3. Gardein Beefless Ground with an SRP of $5.49
  4. Gardein Golden Fishless Filet with an SRP of $5.49
  5. Gardein Lightly Breaded Turk’y Cutlets with an SRP of $5.49

circular economy concept, van Stolk says that SPUD.ca is well aligned to improve recycling streams in the communities the company delivers to as well as to eliminate the amount of packaging entering waste streams altogether.

Canadian online grocery store SPUD.ca stops selling plastic water bottles

By
Editor
-
0

 

Based on a recent survey given to their customers, SPUD.ca CEO Peter van Stolk identified single-use plastic as the gravest environmental concern Canadians have for future generations.  Although the Canadian government released an action plan for reducing plastic pollution by 2021, van Stolk asked customers in an email that announced the ban: “Why to wait to take action?” As a first step, SPUD.ca has discontinued the sale of all single-use plastic water bottles from their website. All still, sparkling, and flavoured water will now only be available in glass bottles and aluminum cans.

Van Stolk shared this insight along with the announcement of the ban: “We recognize that this ban is only a small piece of the puzzle when it comes to taking greater responsibility for the packaging we distribute, but we believe it is more important to start the process than it is to be perfect. At SPUD.ca, we want to exemplify to our community and to the industry that every step is important, and that although the journey to zero waste is long, together we can get there.”

This ban comes just months after the company launched its Pink Bag Takeback program – an initiative that encourages SPUD.ca customers to return the packaging of Be Fresh products, the company’s private-label brand, into their grocery bins that are used to deliver customer’s groceries on a weekly basis. These reusable grocery bins are then picked up by SPUD.ca‘s delivery fleet and the Be Fresh packaging is recycled through the company’s partnership with Terracycle, a specialized recycling organization.

Do single people suffer more?

By
Editor
-
0
Credit: © Antonioguillem / Adobe Stock

 

Researchers at the University of Health Sciences, Medical Informatics and Technology (UMIT, Hall, Austria) and the University of the Balearic Islands (Palma de Mallorca, Spain) have confirmed the analgesic effects of social support – even without verbal or physical contact.

The short communication, entitled “Dispositional empathy is associated with experimental pain reduction during provision of social support by romantic partners” by Stefan Duschek, Lena Nassauer, Casandra I. Montoro, Angela Bair and Pedro Montoya has recently been published in the Scandinavian Journal of Pain.

The authors assessed sensitivity to pressure pain in 48 heterosexual couples with each participant tested alone and in the passive presence of their partner. Dispositional empathy was quantified by a questionnaire.

In the presence, as compared to the absence, of their partners both men and women exhibited higher pain thresholds and tolerance as well as lower sensory and affective pain ratings on constant pressure stimuli. Partner empathy was positively associated with pain tolerance and inversely associated with sensory pain experience.

“Repeatedly, talking and touching have been shown to reduce pain, but our research shows that even the passive presence of a romantic partner can reduce it and that partner empathy may buffer affective distress during pain exposure,” said Professor Stefan Duschek of UMIT, speaking on behalf of the authors.

Materials provided by De Gruyter.
Note: Content may be edited for style and length.

FDA phase 1 trial shows hydrogel to repair heart is safe to inject in humans – a first

By
Editor
-
0

 

The trial is the first to test a hydrogel designed to repair cardiac tissue. It is also the first to test a hydrogel made from the natural scaffolding of cardiac muscle tissue, also known as extracellular matrix, or ECM. This is significant because ECM hydrogels have been shown in preclinical studies to potentially be effective for other conditions, such as poor blood circulation due to peripheral artery disease. The trial showed that the hydrogel, known as VentriGel, can be safely injected via catheter into patients who had suffered a heart attack in the past 2 to 36 months.

“Although the study was designed to evaluate safety and feasibility and not designed to show whether VentriGel effectively helps improve heart function, we observed some improvements in patients,” said Karen Christman, the paper’s senior author and a professor of bioengineering in the Jacobs School of Engineering and the Institute of Engineering in Medicine at UC San Diego. “For example, patients could walk longer distances. We also observed signs of improving heart function in patients who experienced a heart attack more than one year prior to treatment.”

Researchers from Ventrix, led by Christman, report their findings in the Sept. 11 issue of the Journal of the American College of Cardiology: Basic to Translational Science. Dr. Jay Traverse at Minneapolis Heart Institute was the lead clinical investigator.

There are an estimated 785,000 new heart attack cases in the United States each year, with no established treatment for repairing the resulting damage to cardiac tissue. After a heart attack, scar tissue develops, which diminishes muscle function and leads to heart failure. This is where VentriGel comes in. Once injected in damaged cardiac muscle, VentriGel forms a scaffold that acts as a reparative environment where healthy cells migrate, leading to increases in cardiac muscle, less scar tissue, and improvements in heart function.

VentriGel was invented by Christman and her team, then licensed from UC San Diego and developed by Ventrix, Inc, which was cofounded by CEO Adam Kinsey and Christman.

VentriGel is made from cardiac connective tissue taken from pigs, which is stripped of heart muscle cells through a cleansing process. It is then freeze-dried and milled into powder form, and then liquefied into a fluid that can be easily injected into heart muscle in a minimally invasive procedure that does not require surgery. Once it hits body temperature, the liquid turns into a semi-solid, porous gel.

The Phase 1 trial evaluated the gel in 15 patients who sustained moderate damage in the left ventricle chamber of the heart following a heart attack. Each patient received up to 18 injections of VentriGel into the damaged region via catheter. Researchers followed the patients for six months after treatment. All patients completed the full follow-up.

Twelve of the 15 patients were men. All 15 were experiencing mild to moderate heart failure following a heart attack. Half had suffered a heart attack within the past year.

Patients took a six-minute walking test as well as a heart function assessment and a heart health questionnaire before the injections. They retook the tests three and six months later. In addition, patients underwent an MRI at three and six months after the procedures.

Ventrix is now gearing up for a Phase 2 clinical trial that will expand on this successful first-in-human study. They are planning a larger, randomized trial that will evaluate how effectively VentriGel can improve cardiac function and quality of life for patients experiencing heart failure.

Story Source:
Materials provided by University of California – San Diego.
Original written by Ioana Patringenaru.
Note: Content may be edited for style and length.

Molecular basis of vision revealed

By
Editor
-
0
Credit: © BillionPhotos.com / Adobe Stock

 

The findings illuminate how signals from photons (particles of light) get amplified in the eye. More importantly, the study provides insights into how the largest family of cell membrane proteins – G-protein-coupled receptors (GPCRs) – work in humans.

“They’re involved in almost all the biological processes in a human body — how we perceive light, taste, smell, or how the heart rate is regulated or muscles contract — and they are targets for over 30% of the drugs that are used today,” said Yang Gao, co-first author of the paper and a postdoctoral researcher in the lab of Richard Cerione, the Goldwin Smith Professor of Chemistry and Chemical Biology and co-senior author.

There are over 800 GPCRs in humans that signal through about 20 different G proteins. GPCRs are responsible for sensing a wide range of outside signals — such as hormones, light, and sense of smell and taste — and inducing corresponding responses inside the cell. In vertebrate vision, the GPCR rhodopsin is capable of detecting the signal from just one photon and through the activation of the G protein transducin and downstream effectors, amplify it 100,000 times.

The researchers used cryo-electron microscopy to obtain atomic-resolution structures of the rhodopsin-transducin complex. The structures not only provide the molecular basis of vertebrate vision, but also reveal a previously unknown mechanism of how GPCRs in general activate G proteins.

“What we’ve learnt from these structures at an atomic level may be broadly applicable to other GPCR signaling systems,” said co-first author Sekar Ramachandran, a senior research associate in Cerione’s lab.

By learning more about how different receptors specifically couple with different G proteins, the researchers hope to gain insights into designing drugs that specifically regulate GPCR signaling. A lot of drug side effects occur when therapies are not specific enough and target both harmful and beneficial pathways, Yang said.

Hongli Hu, a postdoctoral researcher in Stanford’s Department of Structural Biology, is a co-first author; Georgios Skiniotis, professor of molecular and cellular physiology and of structural biology at Stanford, is a co-senior author.

Story Source:
Materials provided by Cornell University.
Original written by Krishna Ramanujan.
Note: Content may be edited for style and length.

We here at iLevel Management Inc. are excited to let you know that we are growing and have added a brand manager to our team

By
Editor
-
0

 

Nancy has been in the food industry since 1991 starting her career in purchasing, inventory control & participated in the evolution of natural products in Canada.

Through the years she has held roles in distribution & brokerage houses as Senior Brand Manager, Sales & Marketing Manager as well as Director of Business Development. Throughout her diverse career she has established a keen sense of strategy and competitive insight from product development to retail shelves. Nancy is passionate about innovation, delivering success & building trusted relationships along the way.

Please join us in welcoming Nancy to our team. If you have any questions, please let us know.

Nancy can be contacted at:
nanderson@ilevelmanagement.ca
(416)884-6429

As we are continuing to grow and are searching for another brand manager to join our team as well. If you know of anyone that may be interested, please have them reach out.

Canopy Growth Announces Purchase of Majority Stake in BioSteel Sports Nutrition Inc.

By
Editor
-
0
Staff work in a marijuana grow room that can be viewed at the new visitors centre at Canopy Growths Tweed facility in Smiths Falls, Ontario on Thursday, Aug. 23, 2018. The cannabis company has bought a majority stake in BioSteel Sports Nutrition Inc. (Sean Kilpatrick/Canadian Press)

 

The transaction provides Canopy Growth with a significant platform to enter the sports nutrition and hydration segment, and lays the groundwork for the adoption of cannabidiol (“CBD”) in future product offerings in accordance with regulations globally including products to be sold in the U.S. containing CBD sourced from federally permissible industrial hemp.

Founded in 2009, BioSteel’s focus on premium natural ingredients, product transparency, and identifying the essential nutrients needed to power physical activity has led to the brand achieving a reputation for being the hydration product provider of choice for high performance athletes. BioSteel products have been purchased by over 70% of the teams in North America’s four major sports leagues and ambassadors of the brand include: Ezekiel Elliott, of the Dallas Cowboys; Connor McDavid, of the Edmonton Oilers; WTA player, Eugenie Bouchard; Andrew Wiggins with the Minnesota Timberwolves; Tyler Seguin with the Dallas Stars; Jalen Ramsey, with the Jacksonville Jaguars; NHL Hall of Famer, Wayne Gretzky; Gleyber Torres, with the New York Yankees; and Smiths Falls very own, LPGA golfer Brooke Henderson. In particular, Elliott’s agreement with BioSteel allows them to activate the star running back as the leading endorser of CBD products once permitted by the NFL. To date no active player has been able to do so.

In addition, BioSteel has national organizational partnerships with USA Hockey, Canada Basketball, Athletics Canada and the Professional Hockey Players Association. The company has 10,000+ points of distribution in Canada and the U.S. and continues to expand in both markets and into Europe.

“BioSteel has a reputation for being a best-in-class provider of natural sports nutrition products and all of its products are well positioned to benefit from the increasing trend of plant-based and all-natural products, preferred not only by professional athletes, but active consumers as well,” commented Mark Zekulin, CEO, Canopy Growth. “This acquisition allows us to enter the sports nutrition space with a strong and growing brand as we continue towards a regulated market of food and beverage products that contain cannabis. We view the adoption of CBD in future BioSteel offerings as a potentially significant and disruptive growth driver for our business.”

“The use and acceptance of CBD-based products in the professional sports landscape has changed. We have witnessed the negative effects of prescription painkillers and athletes are looking for healthier alternatives,” said Michael Cammalleri, Co-Founder and Co-CEO, BioSteel Sports Nutrition. “Its presence is already commonplace amongst NHL players and as a regular CBD user myself, I couldn’t be more proud to champion BioSteel’s evolution and leadership in this space.”

“Since inception, BioSteel has taken great pride in being at the forefront of healthy and natural sports nutrition. Joining Canopy Growth, the world leader in cannabis research, development and production, reflects the natural evolution of our brand and will allow us to expand our product offering and global distribution,” said John Celenza, Co-Founder and Co-CEO, BioSteel Sports Nutrition. “The consumer market and many of our athletes have a growing knowledge of cannabis and CBD products and this partnership ensures that we will continue to raise the bar in the sports nutrition field.”

Today’s announcement further advances Canopy Growth’s ongoing multi-faceted strategy to enter new markets with a platform spanning production, distribution and marketing of CBD products derived from hemp and cannabis in accordance with regulations across a number of different verticals. The transaction gives Canopy Growth a 72% stake in BioSteel with an agreed upon path to 100% ownership.

Paradigm Capital Inc. has acted as BioSteel’s financial advisor and McCarthy Tetrault LLP has acted as BioSteel’s legal counsel in connection with the transaction.

1...119120121...389Page 120 of 389

EDITOR PICKS

POPULAR POSTS

POPULAR CATEGORY

© 2026 IHR Magazine | Canada's Natural Health Industry Authority | Le guide de l’industrie canadienne de la santé naturelle